1H-imidazo[4,5-c]quinoline derivatives in the treatment of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S081000

Reexamination Certificate

active

07998972

ABSTRACT:
The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase dependent diseases, a method of treatment against said diseases, comprising administering the imidazoloquinolines to a warm-blooded animal, especially a human, pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease, novel imidazoquinolines, and a process for the preparation of the novel imidazoquinolines.

REFERENCES:
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 5525612 (1996-06-01), Gerster
patent: 5605899 (1997-02-01), Gerster
patent: 145340 (1985-06-01), None
patent: 0145340 (1985-06-01), None
patent: 307078 (1989-03-01), None
patent: 0310950 (1989-04-01), None
patent: 386722 (1990-09-01), None
patent: 0389302 (1990-09-01), None
patent: 441036 (1990-12-01), None
patent: 1104764 (2001-06-01), None
patent: 1256582 (2002-11-01), None
patent: 11080156 (1997-09-01), None
patent: WO 9215582 (1992-09-01), None
patent: WO 99/09029 (1999-02-01), None
patent: WO 0009506 (2000-02-01), None
patent: WO 0055154 (2000-09-01), None
patent: WO 0076519 (2000-12-01), None
patent: WO 0146190 (2001-06-01), None
patent: WO 01/97795 (2001-12-01), None
patent: WO 0246188 (2002-06-01), None
Brown, T.H. et al., Journal of Medicinal Chemistry, American Chemical Society, 33, pp. 527-533 (1990).
U.S. Appl. No. 10/579,867, commonly assigned to Novartis.
U.S. Appl. No. 11/913,788, commonly assigned to Novartis.
Kato, et al. (Document No: 132: 180573) retrieved from Caplus on Jun. 7, 2010.
Brown, et al. J. Med. Chem. 1990, 33, 527-533.
Isomers [online], [retrieved on Mar. 11, 2007]. Retrieved from the Internet, URL; http ://chemed.chem.purdue.edu/genchem/topicreview/bp/ I organic/isomers.html>.
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL http://www.nlm.nih.gov/medlineplus/cancer.html>.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL; http://en.wikipedia.orglwikilCancer.
Megyeri, K. et al., Molecular and Cellular Biology, 15, No. 4, pp. 2207-2218 (Apr. 1, 1995).
Lee, J.C. et al., Nature, 372, pp. 739-746 (Dec. 22, 1994).
Brown, T.H. et al., Journal of medicinal Chemistry, American Chemical Society, 33, pp. 527-533 (1990).
R.L.A. Bottrel et al., Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 43, No. 4., pp. 856-861 (Apr. 1999).
G.A. Bishop et al., The Journal of Immunology, 165, No. 10, pp. 5552-5557 (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1H-imidazo[4,5-c]quinoline derivatives in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1H-imidazo[4,5-c]quinoline derivatives in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-imidazo[4,5-c]quinoline derivatives in the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2781336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.